health-it is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Genomic Trial, the most common co-covered peer. Source depth averages 2 original sources per story, versus 2.5 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Kiwis
health-it is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Genomic Trial, the most common co-covered peer. Source depth averages 2 original sources per story, versus 2.5 across the same-window beat baseline. The 7 average consequence score is above the beat benchmark of 5.8 in the same window. We currently track 1 Healthcare story that mention Kiwis, all published on March 18, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 24 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Kiwis. Shared-story counts are live from our verified record — not editorial picks.
New Zealand has initiated a landmark genomic trial designed to bring advanced diagnostic testing onshore for patients with cancer and rare disorders. The program aims to reduce the 'diagnostic odyssey' by eliminating the need to send biological samples to overseas laboratories.